CURR News and Press, Cure Pharmaceutical Holding Corp From 08/21/19

OXNARD, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has signed a deal with Oklahoma-based hemp grower Fytiko Farms. The deal gives CURE direct, guaranteed access to high-quality plant ...

Earlier this year I discussed why I am bearish overall on Cronos Group Inc ( CRON ), but I did note the company's partnership with Ginkgo Bioworks was a key part of the bull thesis. That partnership sees Ginkgo attempting produce cannabinoids via biosynthesis using yeast, rather than by ...

OXNARD, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No. 13/890,875. The new patent builds on one of CURE’s key technology differentiators – ...

OXNARD, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No. 15/666,057, which covers edible thin films with natural active ingredients located in both a powde...

CURE Pharmaceutical ( OTCQB:CURR ) is working with Canopy Growth (NYSE: CGC ) to develop a new low-dose cannabidiol oral thin film using Cure's patented CUREfilm technology for global distribution. More news on: CURE Pharmaceutical Holding Corp., Canopy Growth Corporation, Healthcare sto...

OXNARD, Calif. , June 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it is collaborating with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), (“Canopy”) to develop a new low-dose cannabi...

LOS ANGELES, May 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 9 th Annual LD Micro Invitational on Wednesday, June 5 th at 11:40 a.m. PT at the Luxe Sunset Boulevard...

OXNARD, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the issuance of U.S. Patent No. 10,307,397, which covers the high load of bioactive cannabinoid molecules integrated into oral thin ...

CURE Pharmaceutical ( OTCQB:CURR ) has announced four key hires to grow their leadership team. More news on: CURE Pharmaceutical Holding Corp., Healthcare stocks news, Read more ...

OXNARD, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the addition of four key hires to their growing leadership team. Michael Redard will serve as CURE’s Chief Financial Officer. Jos...